FDA
approval
· 2021-02-04
FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Carbidopa and Levodopa from Teva Pharmaceuticals USA, Inc., updating the product under the existing approval.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)